High FSH:LH ratio and low LH levels in basal cycle day 3:: Impact on follicular development and IVF outcome

被引:43
作者
Barroso, G [1 ]
Oehninger, S [1 ]
Monzó, A [1 ]
Kolm, P [1 ]
Gibbons, WE [1 ]
Muasher, SJ [1 ]
机构
[1] Eastern Virginia Med Sch, Dept Obstet & Gynecol, Jones Inst Reprod Med, Norfolk, VA 23507 USA
关键词
basal serum LH/FSH : LH ratio; fertilization; implantation; pregnancy; preovulatory oocytes;
D O I
10.1023/A:1016601110424
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose. To examine the impact of low basal cycle day 3 serum LH levels or a high FSH.-LH ratio on IVF results. Methods. A homogeneous group of patients was analyzed as identified by normal basal cycle of follicle stimulating hormone (FSH), Luteinizing hormone (LH), and estradiol (E-2) levels. High responders (high LH:FSH ratio) and low responders (high FSH or E2 levels, and women greater than or equal to 42 years of age) were excluded from analysis. Only cycles stimulated with a combination of a GnRHa (luteal suppression) and pure FSH were studied. Results. Patients with low basal LH levels (<3 mIU/mL) did not differ significantly from controls in terms of response to controlled ovarian hyperstimulation but there was a clear trend toward poorer implantation and clinical pregnancy rates. On the other hand, patients with a high FSH.-LH ratio (>3) had significantly fewer mature oocytes aspirated, and lower implantation and clinical pregnancy rates than patients with gonadotropin ratio <3. These negative effects were evident in the presence of normal basal FSH levels and after adequate matching of female's age and number of embryos transferred. Conclusions. These studies highlight a negative impact of a basal cycle high FSH.-LH ratio (and possibly low LH levels) on follicular development and oocyte quality in these patients subjected to pituitary down-regulation followed by pure FSH administration. A high FSH.-LH ratio may be therefore used as an early biomarker of poor ovarian response.
引用
收藏
页码:499 / 505
页数:7
相关论文
共 24 条
[1]   THE POOR-RESPONDER PATIENT IN AN IN-VITRO FERTILIZATION-EMBRYO TRANSFER PROGRAM [J].
BENRAFAEL, Z ;
FELDBERG, D .
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 1993, 10 (02) :118-120
[2]   The value of basal serum follicle stimulating hormone, luteinizing hormone and oestradiol concentrations following pituitary down-regulation in predicting ovarian response to stimulation with highly purified follicle stimulating hormone [J].
Develioglu, OH ;
Cox, B ;
Toner, JP ;
Oehninger, S ;
Muasher, SJ .
HUMAN REPRODUCTION, 1999, 14 (05) :1168-1174
[3]   Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome [J].
Loumaye, E ;
Engrand, P ;
Howles, CM ;
ODea, L .
FERTILITY AND STERILITY, 1997, 67 (05) :889-899
[4]   STIMULATION OF LH FRAGMENTS WITH REDUCED BIOACTIVITY FOLLOWING GNRH AGONIST ADMINISTRATION IN WOMEN [J].
MELDRUM, DR ;
TSAO, Z ;
MONROE, SE ;
BRAUNSTEIN, GD ;
SLADEK, J ;
LU, JKH ;
VALE, W ;
RIVIER, J ;
JUDD, HL ;
CHANG, RJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1984, 58 (04) :755-757
[5]   Improved oocyte quality is obtained with follicle stimulating hormone alone than with follicle stimulating hormone human menopausal gonadotrophin combination [J].
Mercan, R ;
Mayer, JF ;
Walker, D ;
Jones, S ;
Oehninger, S ;
Toner, JP ;
Muasher, SJ .
HUMAN REPRODUCTION, 1997, 12 (09) :1886-1889
[6]  
MEYER WR, 1990, OBSTET GYNECOL, V75, P795
[7]  
MUASHER SJ, 1988, FERTIL STERIL, V50, P298
[9]  
MUASHER SJ, 1992, CLIN THER, V14, P74
[10]  
MURKHERJEE T, 1995, 51 ANN M AM SOC REPR